Sie suchten nach: 2,3,6-Trifluorbenzylbromid

Artikel-Nr: (EHERC17773600)

Lieferant: EHRENSTORFER

Beschreibung: 2,3,6-Trichlorphenol

UOM: 1 * 0,1 g

Aktion

Lieferant: Apollo Scientific

Beschreibung: Vancomycin is a glycopeptide antibiotic. It exerts its action by inhibiting the formation of the peptidoglycan polymers of the bacterial cell wall. Often used incombination with cefotaxim or carbenicillin.

Artikel-Nr: (SIAL345725-5G)

Lieferant: Merck

Beschreibung: 2,3,6-Trifluorphenol, Sigma-Aldrich®

UOM: 1 * 5 g

Aktion

Artikel-Nr: (BOSSBS-9500R-CY5)

Lieferant: Bioss

Beschreibung: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Aktion

Artikel-Nr: (SIAL325198-1G)

Lieferant: Merck

Beschreibung: 2,3,6-Trifluorbenzoesäure, Sigma-Aldrich®

UOM: 1 * 1 g

Aktion

Artikel-Nr: (BOSSBS-9500R-A750)

Lieferant: Bioss

Beschreibung: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation. Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesised in the liver and circulates as an inactive precursor. Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds. Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease.

UOM: 1 * 100 µl

Aktion

Artikel-Nr: (BOSSBS-9500R-A647)

Lieferant: Bioss

Beschreibung: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Aktion

Artikel-Nr: (BOSSBS-9500R-A488)

Lieferant: Bioss

Beschreibung: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Aktion

Artikel-Nr: (EHERC17713600)

Lieferant: EHRENSTORFER

Beschreibung: 2,3,6-Trichloranisol

UOM: 1 * 0,1 g

Aktion

Artikel-Nr: (BOSSBS-9500R-CY3)

Lieferant: Bioss

Beschreibung: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Aktion

Artikel-Nr: (BOSSBS-9500R-FITC)

Lieferant: Bioss

Beschreibung: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Aktion

Artikel-Nr: (EHERL17713600CY)

Lieferant: EHRENSTORFER

Beschreibung: Organic Standard, 2,3,6-Trichloranisol 10 µg/ml in Cyclohexan, Packung: Glasflasche

UOM: 1 * 10 mL

Aktion

Artikel-Nr: (EHERC11247000)

Lieferant: EHRENSTORFER

Beschreibung: Chlorfenac

UOM: 1 * 0,1 g

Aktion

Artikel-Nr: (HEWL9300-0311)

Lieferant: Agilent

Beschreibung: Snoop, 236 ml bottle, Optiflow

UOM: 1 * 1 ST

Aktion

Artikel-Nr: (ABNOMAB3666)

Lieferant: Abnova

Beschreibung: Mouse monoclonal antibody raised against recombinant ADIPOQ.

UOM: 1 * 1 mg

Aktion

Artikel-Nr: (EHERL17773600ME)

Lieferant: EHRENSTORFER

Beschreibung: Organic Standard, 2,3,6-Trichlorphenol 10 µg/ml in Methanol, Packung: Glasflasche

UOM: 1 * 10 mL

Aktion